ASCO Presentation Points to Clinically Relevant Mutations in Subset of Biliary Tract Tumors | GenomeWeb

CHICAGO (GenomeWeb) – A study presented at this week's American Society of Clinical Oncology annual meeting may have uncovered clinically actionable mutations in a significant subset of difficult-to-treat, advanced biliary cancers tested by targeted sequencing. 

Milind Javle, a gastrointestinal medical oncology researcher with the University of Texas MD Anderson Cancer Center, presented the work and shared vignettes about biliary tract cancer cases in which treatment was targeted based on the mutations identified. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.

Sponsored by
Agilent Technologies

This webinar will discuss a genomic strategy that detects single nucleotide variants and copy number variants in a single assay.

Sponsored by

This webinar will be an interactive roundtable discussion on established and emerging regulatory, scientific, and medical topics related to next-generation sequencing in the clinical setting.